Blonder Tongue Laboratories Inc (BDRLQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -902 | -2,822 | -5,157 | -411 | 1,785 |
| Depreciation Amortization | 1,415 | 1,314 | 1,438 | 1,141 | 828 |
| Income taxes - deferred | 32 | 33 | 2,311 | 0 | N/A |
| Accounts receivable | 836 | 220 | 1,543 | -838 | 367 |
| Other Working Capital | 382 | 2,858 | 3,133 | -922 | -178 |
| Other Operating Activity | -148 | 258 | 372 | 1,269 | 269 |
| Operating Cash Flow | $1,615 | $1,861 | $3,640 | $239 | $3,071 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -673 | -154 | -6,992 | -200 | -117 |
| Purchase Sale Intangibles | -554 | -847 | -576 | -672 | -1,023 |
| Other Investing Activity | -554 | -847 | -576 | -672 | -1,023 |
| Investing Cash Flow | $-1,227 | $-1,001 | $-7,568 | $-872 | $-1,140 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -6 | -969 | 2,244 | 0 | N/A |
| Debt Issued | N/A | N/A | 1,551 | 0 | 21,936 |
| Debt Repayment | -270 | -277 | -265 | -259 | -22,169 |
| Common Stock Issued | 53 | N/A | N/A | 26 | 5 |
| Financing Cash Flow | $-223 | $-1,246 | $3,530 | $-233 | $-228 |
| Beginning Cash Position | 67 | 453 | 851 | 1,717 | 14 |
| End Cash Position | 232 | 67 | 453 | 851 | 1,717 |
| Net Cash Flow | $165 | $-386 | $-398 | $-866 | $1,703 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,615 | 1,861 | 3,640 | 239 | 3,071 |
| Capital Expenditure | -673 | -154 | -7,122 | -200 | -117 |
| Free Cash Flow | 942 | 1,707 | -3,482 | 39 | 2,954 |